Brief: Sino Biopharmaceutical Says SBP Group To Buy 5% Equity Interest In CT Tianqing For RMB4.48 Billion At 19X LTM P/E
11/09/2026 11:26
BRIEF-Sino Biopharmaceutical Says SBP Group To Buy 5% Equity Interest In CT Tianqing For RMB4.48 Billion At 19X LTM P/E Sept 11 (Reuters) - Sino Biopharmaceutical Limited 1177.HK:
SBP GROUP TO BUY 5% EQUITY INTEREST IN CT TIANQING FOR RMB4.48 BILLION AT 19X LTM P/E
Further company coverage: 1177.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sino Biopharmaceutical
See all newsHong Kong stocks end higher on pharma, tech gains
Hong Kong stocks climb, led by pharmaceutical, tech stocks
Brief: Sino Biopharmaceutical Says China's CDE Accepts NDA For TQH2722 Injection
Brief: Sino Biopharmaceutical China CDE Accepts New Drug Application For TQB2102 Injection
Sino Biopharmaceutical climbs on plan to raise stake in core unit